Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3990589 | Journal of Thoracic Oncology | 2010 | 7 Pages |
Abstract
In a contemporary population representing the full age range of patients with advanced NSCLC, chemotherapy was administered to approximately half of all patients-more than twice the rate reported in some earlier studies. Patient age and insurance type are associated with receipt of chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Drew W. MD, Jingsheng PhD, Yang PhD, Jonathan E. MD, David E. MD,